Hls Therapeutics Inc (HLS.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Sales | 0 | 73,877 | 79,466 | 116,556 | 78,746 |
| Cost of Goods | -215 | 53,029 | 62,506 | 91,426 | 58,240 |
| Gross Profit | 215 | 20,848 | 16,960 | 25,130 | 20,506 |
| Operating Expenses | 2,681 | 4,682 | 4,485 | 3,146 | 4,134 |
| Operating Income | -2,466 | 16,166 | 12,476 | 21,984 | 16,372 |
| Interest Expense | N/A | N/A | 9 | 13 | 40 |
| Other Income | 249 | 825 | 356 | 604 | 86 |
| Pre-tax Income | -2,217 | 16,992 | 12,822 | 22,575 | 16,418 |
| Income Tax | -485 | 4,274 | 3,090 | 5,708 | 4,088 |
| Net Income Continuous | -1,732 | 12,717 | 9,733 | 16,867 | 11,983 |
| Net Income | $-1,732 | $12,717 | $9,733 | $16,867 | $11,983 |
| EPS Basic Total Ops | -0.10 | 0.66 | 0.49 | 0.83 | 0.60 |
| EPS Basic Continuous Ops | -0.10 | 0.66 | 0.49 | 0.83 | 0.60 |
| EPS Diluted Total Ops | -0.10 | 0.66 | 0.49 | 0.83 | 0.60 |
| EPS Diluted Continuous Ops | -0.10 | 0.66 | 0.49 | 0.83 | 0.60 |
| EBITDA(a) | $-2,466 | $20,014 | $18,820 | $29,683 | $22,292 |